Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
140
Publications with fulltext
Open Access
53 %
Mots clés
CONGENITAL MYATHENIC SYNDROME
Acute coronary syndrome
Mouse models
Hypoxia
Mice
Cell model
Centronuclear myopathy
RNA splicing
Myelin
Brain dysfunction
Exercise
Transgenic mouse
Motoneuron
Intermediate filament
Cardiac muscle
Expression
Gene editing
Myotonic Dystrophy
Dystrophin
Exercice
Desmin
DM1
Neuron
Transgenic mouse model
Autophagy
Thérapie génique
Fibrosis
Diaphragm
PCR
Acetylcholinesterase knockout mouse
Transcriptomics
Myotonic dystrophy mouse models
AAV
RNA interference
GABA
Central nervous system
CRISPR/Cas9
PacBio
Muscular dystrophy
ARN
Maximal force
Long read sequencing
Duchenne muscular dystrophy
Glial cells
DMSXL mice
ACETYLCHOLINESTERASE
Brain
Trinucleotide Repeat Expansion
CRISPRi
Cell culture model
Astrocytes
Gene therapy
Glutamate
Dystrophie Myotonique
CMS
Quantitative microdialysis
Mouse model
BIOLOGIE MOLECULAIRE
Cell penetrating peptide
In vivo
CTG repeat contractions
Glucocorticoid-receptor
Myostatin
Trinucleotide repeat expansion
Astrocyte
Heart
MBNL
Alternative splicing
Male
Endurance training
CTG repeats
GSK3
Therapy
Heart failure
Antisense oligonucleotides
Myotonic dystrophy
Dystrophie myotonique
Humans
Gene Therapy
Acetylcholinesterase deficiency
Myotonic dystrophy type 1
Glucocorticoids
Genotype phenotype correlation
Oligodendrocytes
Myotonic Dystrophy Type 1
Oligodendrocyte
Skeletal muscle
Dynamin 2
Knockout
DMPK
Myotonic Dystrophy type 1
Antisense oligonucleotide
Aging
Muscle
KNOCKOUT MICE
Animals
Dilated cardiomyopathy
Cytoskeleton
CTG repeat instability
RNA biology